
The Global Fund is seeking £11 billion worth of investment in an attempt to save 16 million lives in the …

Japanese pharma and biotech firm Kyowa Hakko Kirin is joining the growing trend of investing in artificial intelligence to bolster …

With the completion of Takeda’s £46 billion acquisition of Shire finally done, another even bigger merger was announced as US …

It’s only the second week of the New Year, and Johnson & Johnson has announced plans to hike the prices …

Senator Bernie Sanders has called on President Donald Trump to support new legislation aimed at cutting prices on prescription drugs. …

A new partnership between the UK and Japan will see medical researchers and scientists join forces, in advancing research into …

Roche subsidiary, Foundation Medicine, today announced the appointment of Roche’s senior vice president in global oncology, Cindy Perettie as the …

UK-based drug firm AstraZeneca has revealed it is set to shed more than 200 positions from its operations at two …

Scientists at the University of Texas Medical Branch (UTMB) in Galveston, Texas have developed a new experimental drug that protects …

It’s disappointing news for Novartis as NICE revealed that it had decided not to recommend Aimovig (erenumab) for routine NHS …

The FDA approved a record 971 generic drugs in the 2018 fiscal year, giving the go-ahead to 110 generics in …

Commonly used anti-cholesterol drugs, blood pressure drugs and medicines used for diabetes may improve the mental health of those with …

Amgen has revealed that its bone-forming monoclonal antibody Evenity (romosozumab), developed in partnership with UCB Pharma, has been awarded approval …

Scott Dozier, the death row inmate whose execution was stalled by court cases launched by pharmaceutical companies, has been found …

Health officials from Public Health England (PHE) have warned that cases of antibiotic resistant strains of the sexually transmitted infection …

Pfizer has announced it is to shut down two of its manufacturing facilities in India – a move which could …

In the past, observational studies have found a link between the use of common nonsteroidal anti-inflammatory drugs (NSAIDs) and increased …

bluebird bio, a US-based gene therapy biotech with a focus on cancer and severe genetic conditions, has named Nicola Redfern …

The Anglo-Swedish multinational AstraZeneca has named Dr José Baselga as the firm’s new head of research and development in oncology.The …

A team of researchers at the University of Birmingham has identified a pair of biomarkers which it says could aid …